Join to View Full Profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Are you Dr. Lowe?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Val Lowe, MD is a board certified nuclear medicine physician in Rochester, Minnesota. He is currently licensed to practice medicine in Minnesota, Florida, and Georgia. He is a Professor at Mayo Medical School.
Education & Training
Duke University HospitalResidency, Nuclear Medicine, 1991 - 1994
LDS HospitalResidency, Internal Medicine, 1988 - 1991
McGill University Faculty of MedicineClass of 1988
Certifications & Licensure
FL State Medical License 2013 - 2027
AZ State Medical License 2001 - 2026
UT State Medical License 1989 - 2026
MN State Medical License 1999 - 2025
WI State Medical License 2013 - 2025
IA State Medical License 2013 - 2023
GA State Medical License 2013 - 2016
American Board of Nuclear Medicine Nuclear Medicine- Join now to see all
Publications & Presentations
PubMed
- Eligibility for donanemab trial in a population-based study of cognitive aging.Katherine E Jones, Jeremiah A Aakre, Anna M Castillo, Vijay K Ramanan, Walter K Kremers
The Journal of Prevention of Alzheimer's Disease. 2025-04-01 - Longitudinal FDG-PET Metabolic Change Along the Lewy Body Continuum.Daniel Ferreira, Scott A Przybelski, Timothy G Lesnick, Patricia Diaz-Galvan, Christopher G Schwarz
JAMA Neurology. 2025-03-01 - Plasma Alzheimer's disease biomarker relationships with incident abnormal amyloid PET.Petrice M Cogswell, Heather J Wiste, Stephen D Weigand, Terry M Therneau, Michael E Griswold
Alzheimer's & Dementia. 2025-02-01
Press Mentions
Meet Mukesh Pandey, Ph.D. – Developing a New Drug to Detect Prostate Cancer in Its Earliest StagesSeptember 23rd, 2019
Surgical Planning for Head and Neck Cancer Benefits from FDG-PET/CTAugust 7th, 2019- Game Changers: Five Innovative Tests for Cancer DetectionSeptember 21st, 2017
- Join now to see all
Grant Support
- Amyloid beta peptides and type-2 diabetes sequelae synergistically inhibit insulin signaling and trafficking at the blood brain barrierUNIVERSITY OF MINNESOTA2022–2027
- Tau PET/CT for Early Detection of Alzheimer’s Disease PathologyMAYO CLINIC ROCHESTER2021–2026
